Reduced susceptibility of Clostridium difficile to metronidazole

被引：73

作者：

Brazier, JS

Fawley, W

Freeman, J

Wilcox, MH ^{[1
]}

机构：

[1] Univ Wales Hosp, PHLS Anaerobe Reference Unit, Cardiff CF4 4XW, S Glam, Wales

[2] Univ Leeds, Dept Microbiol, Leeds LS2 9JT, W Yorkshire, England

[3] Gen Infirm, Leeds LS2 9JT, W Yorkshire, England

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2001年 / 48卷 / 05期

关键词：

D O I：

10.1093/jac/48.5.741

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

收藏

页码：741 / 742

页数：2

相关论文

共 5 条

[1] FECAL METRONIDAZOLE CONCENTRATIONS DURING ORAL AND INTRAVENOUS THERAPY FOR ANTIBIOTIC ASSOCIATED COLITIS DUE TO CLOSTRIDIUM-DIFFICILE
BOLTON, RP
CULSHAW, MA
[J]. GUT, 1986, 27 (10) : 1169 - 1172
[2] Molecular epidemiology of endemic Clostridium difficile infection
Fawley, WN
Wilcox, MH
[J]. EPIDEMIOLOGY AND INFECTION, 2001, 126 (03) : 343 - 350
[3] Antimicrobial susceptibilities of equine isolates of Clostridium difficile and molecular characterization of metronidazole-resistant strains.
Jang, SS
Hansen, LM
Breher, JE
Riley, DA
Magdesian, KG
Madigan, JE
Tang, YJ
Silva, J
Hirsh, DC
[J]. CLINICAL INFECTIOUS DISEASES, 1997, 25 : S266 - S267
[4] PELAEZ T, 1997, 38 INT C ANT AG CHEM
[5] Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest
Wong, SSY
Woo, PCY
Luk, WK
Yuen, KY
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 34 (01) : 1 - 6